UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

Annals of oncology, 2018-06, Vol.29 (6), p.1437-1444

2018

Volltextzugriff (PDF)

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Annals of oncology, 2019-08, Vol.30 (8), p.1311-1320

2019

Volltextzugriff (PDF)

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

Annals of oncology, 2020-05, Vol.31 (5), p.599-608

2020

Volltextzugriff (PDF)

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Annals of oncology, 2018-10, Vol.29 (10), p.2085-2091

2018

Volltextzugriff (PDF)

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

The Lancet (British edition), 2010-08, Vol.376 (9741), p.595-605

2010

Volltextzugriff (PDF)

Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women

The American journal of clinical nutrition, 2011-07, Vol.94 (1), p.209-217

2011

Volltextzugriff (PDF)

Deciphering radiological stable disease to immune checkpoint inhibitors

Annals of oncology, 2022-08, Vol.33 (8), p.824-835

2022

Volltextzugriff (PDF)

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Annals of oncology, 2016-07, Vol.27 (7), p.1286-1291

2016

Volltextzugriff (PDF)

Investigation of patterns of nodal metastases in BRAF mutant lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-06, Vol.108, p.62-65

2017

Volltextzugriff (PDF)

Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer

Clinical radiology, 2018-05, Vol.73 (5), p.505.e1-505.e8

2018

Volltextzugriff (PDF)

P14.26 Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S341-S341

2021

Volltextzugriff (PDF)

Diagnosis and treatment of patients with thyroid cancer

American health & drug benefits, 2015-02, Vol.8 (1), p.30-40

2015

Volltextzugriff (PDF)

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Diabetes care, 2013-12, Vol.36 (12), p.4022-4029

2013

Volltextzugriff (PDF)

Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity

Expert opinion on pharmacotherapy, 2009-04, Vol.10 (6), p.1069-1081

2009

Volltextzugriff (PDF)

Medical nutrition: a comprehensive, school-wide curriculum review

The American journal of clinical nutrition, 2006-04, Vol.83 (4), p.963S-967S

2006

Volltextzugriff (PDF)

P02.14 Radiotherapy-Associated CT Imaging as a Potential Screening Tool for COVID-19

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S252-S252

2021

Volltextzugriff (PDF)

P1.01-76 A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S492-S492

2018

Volltextzugriff (PDF)

MA11.01 Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S290-S290

2019

Volltextzugriff (PDF)

A108 LITTLE RED CLOT: NEW FRONTIERS IN THE MANAGEMENT OF ACUTE AND CHRONIC THROMBOEMBOLIC DISEASE: Performance Of The Revised Geneva Score In Evaluation For Pulmonary Embolism At A Cancer Hospital

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines

Endocrine practice, 2016-07, Vol.22 (7), p.842-884

2016

Volltextzugriff (PDF)

MA19.09 Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S424-S424

2018

Volltextzugriff (PDF)

P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S574-S575

2019

Volltextzugriff (PDF)

Medical nutrition therapy for the treatment of obesity

Endocrinology and Metabolism Clinics of North America, 2003-12, Vol.32 (4), p.935-965

2003

Volltextzugriff (PDF)

P1.03-028 A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Untreated Stage IV Squamous Cell Lung Cancers

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1961-S1962

2017

Volltextzugriff (PDF)

MA 05.02 STK11/LKB1 Loss of Function Genomic Alterations Predict Primary Resistance to PD-1/PD-L1 Axis Blockade in KRAS-Mutant NSCLC

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1815-S1815

2017

Volltextzugriff (PDF)

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(152)
Mit Volltextzugriff
(156)

Publikationsform

Sprache

Englisch
(171)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(95)
Science & Technology
(95)
Humans
(77)
Oncology
(52)
Female
(43)
Male
(43)
Aged
(38)
Middle Aged
(38)
Adult
(28)
Lung Neoplasms - Drug Therapy
(27)
Lung Neoplasms - Genetics
(24)
Retrospective Studies
(24)
Lung Neoplasms - Pathology
(23)
Radiology, Nuclear Medicine & Medical Imaging
(23)
Lung Cancer
(20)
Mutation
(20)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(19)
Patients
(18)
Aged, 80 And Over
(17)
Respiratory System
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer

EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial

Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women

Deciphering radiological stable disease to immune checkpoint inhibitors

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Investigation of patterns of nodal metastases in BRAF mutant lung cancer

Imaging skeletal muscle volume, density, and FDG uptake before and after induction therapy for non-small cell lung cancer

P14.26 Diminished Efficacy of PD-(L)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma is Impacted by KRAS Mutation Status

Diagnosis and treatment of patients with thyroid cancer

Effects of Naltrexone Sustained-Release/Bupropion Sustained-Release Combination Therapy on Body Weight and Glycemic Parameters in Overweight and Obese Patients With Type 2 Diabetes

Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity

Medical nutrition: a comprehensive, school-wide curriculum review

P02.14 Radiotherapy-Associated CT Imaging as a Potential Screening Tool for COVID-19

P1.01-76 A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers

MA11.01 Multifactorial Model to Predict Response to PD-(L)1 Blockade in Patients with High PD-L1 Metastatic Non-Small Cell Lung Cancer

A108 LITTLE RED CLOT: NEW FRONTIERS IN THE MANAGEMENT OF ACUTE AND CHRONIC THROMBOEMBOLIC DISEASE: Performance Of The Revised Geneva Score In Evaluation For Pulmonary Embolism At A Cancer Hospital

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITYEXECUTIVE SUMMARYComplete Guidelines available at https://www.aace.com/publications/guidelines

MA19.09 Concurrent Mutations in STK11 and KEAP1 is Associated with Resistance to PD-(L)1 Blockade in Patients with NSCLC Despite High TMB

P1.14-50 A Phase 2 Trial of Cabozantinib in ROS1-Rearranged Lung Adenocarcinoma

Medical nutrition therapy for the treatment of obesity

P1.03-028 A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Untreated Stage IV Squamous Cell Lung Cancers

MA 05.02 STK11/LKB1 Loss of Function Genomic Alterations Predict Primary Resistance to PD-1/PD-L1 Axis Blockade in KRAS-Mutant NSCLC

Suchergebnisse filtern